Prosecution Insights
Last updated: April 19, 2026
Application No. 17/721,104

PROCESS FOR PRODUCING A CELLULOSIC FUNCTIONAL FIBRE WITH HIGH ION EXCHANGE CAPACITY, CELLULOSIC FUNCTIONAL FIBRE, TEXTILE PRODUCT COMPRISING CELLULOSIC FUNCTIONAL FIBRE, AND GARMENT OR PIECE OF FURNITURE COMPRISING SAID CELLULOSIC FUNCTIONAL FIBRE OR TEXTILE PRODUCT

Non-Final OA §103
Filed
Apr 14, 2022
Examiner
KHAN, AMINA S
Art Unit
1761
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Smartfiber AG
OA Round
1 (Non-Final)
48%
Grant Probability
Moderate
1-2
OA Rounds
3y 4m
To Grant
91%
With Interview

Examiner Intelligence

Grants 48% of resolved cases
48%
Career Allow Rate
484 granted / 1008 resolved
-17.0% vs TC avg
Strong +43% interview lift
Without
With
+43.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
66 currently pending
Career history
1074
Total Applications
across all art units

Statute-Specific Performance

§101
0.5%
-39.5% vs TC avg
§103
62.2%
+22.2% vs TC avg
§102
11.1%
-28.9% vs TC avg
§112
17.2%
-22.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1008 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claims 1-11 and 13-15 are pending. Claim 12 has been cancelled. Claims 11 and 13-15 have been amended. Applicant's election with traverse of claims 1-10 in the reply filed on October 10, 2025 is acknowledged. Applicant has amended the non-elected claims to be process claims dependent upon claims, therefore the restriction requirement is moot. Claims 1-11 and 13-15 are now a single invention drawn to a single process and will be examined together as a group. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-5,7,9,11,13 and 15 are rejected under 35 U.S.C. 103 as being unpatentable over Marialma (Bed Sheets: How We Turn Seaweed into Luxury Fabrics) in view of Qin (Alginate fibers: an overview of the production process and applications in wound management), Rioux (Characterization of polysaccharides extracted from brown seaweeds.) and Meister (EP0860522A1). Marialma teaches producing harvesting seaweed (raw plant material containing polymer-bound uronic acids from marine plant stalks), extracting part of the seaweed, using a lyocell process to incorporate seaweed into a natural cellulose fiber and preparing textile fabrics from yarns such as bed sheets (furniture containing a portion of the seaweed fiber). Marialma does not teach extracting the raw material using an extractant in order to provide extracted polymer-bound uronic acid-containing plant material and spinning the spinning solution. Marialma does not teach 0.1-15% extracted, polymer bound uronic acid containing plant material combined with cellulose calculated based on the weight of the cellulose contained in the spinning solution. Qin teaches that alginate fibers are conventionally made from sodium alginate which is a natural polymer extract from brown seaweeds (abstract) and are made into woven, non-woven and knitted textiles (page 171, right column, introduction, first paragraph). Qin teaches the seaweed stalks are harvested and alginate extracted wherein the alginate contains uronic acids such as β-D-mannuronic and [Symbol font/0x61]-L-guluronic acids (page 172, right column). Qin teaches the alginate is spun into fibers (page 173, left column, preparation of spinning solutions), extruding the solution into a calcium chloride (alkaline earth metal salt having a water solubility of at least 100g/L at 20°C) or zinc chloride containing coagulation bath (page 172, left and right column, production of calcium alginate fibers). Rioux teaches brown seaweeds can be extracted by treating with 85% ethanol.(extractant, organic solvent, alcohol) and using the residual seaweed (components of the raw plant that do not dissolve in extractant), treating with CaCl2 (alkaline earth metal salt having a water solubility of at least 100g/L at 20°C) at 2% w/v to precipitate the alginates (page 531, section 2.2). Meister teaches that making fibers from uronic acid containing polysaccharides (abstract, paragraph 0013, claim 3, claim 24) wherein the polysaccharides are combined with the 1-99% of the cellulose (paragraph 0015) leaving 1-99% for the polysaccharide. It would have been obvious to one of ordinary skill in the art at the time the invention was made to modify the methods of Marialma by extracting the alginates from seaweeds using a 85% ethanol in water solvent, taking the extraction residue that did not dissolve in the extractant and adding calcium chloride to precipitate the alginate and use the alginate to form a spinning dope which is spun into a 2% calcium chloride coagulating bath for preparing fibers for bed sheets as Qin teaches alginate fibers are conventionally prepared by extraction from brown seaweeds and spinning of the alginate extract and the alginates contain polymer-bound uronic acids containing plant material and Rioux teaches the claimed water ethanol solvent extraction, addition of CaCl2 before spinning and also in the coagulation bath to solidify the alginate fibers. Marialma invites the inclusion of extracting seaweed to produce luxury fibers for bedding material and Qin teaches a method for extracting alginate from seaweed and spinning into fibers which can be woven, non-woven or knitted into textiles. Using the extraction mechanism of Rioux and coagulation of the spinning dope in CaCl2 into fibers would be an effective method to incorporate into the method to isolate and spin the alginate. It would have been obvious to one of ordinary skill in the art at the time the invention was made to modify the methods of Marialma by using a 1-15% polymer-bound uronic acid-containing plant material combined with cellulose based on the amount of cellulose in the spinning solutions as Meister teaches the uronic acids and cellulose added at these amounts provide the fibers with bactericidal and fungicidal properties and shape-giving supporting function. Claims 8 and 10 are rejected under 35 U.S.C. 103 as being unpatentable over Marialma (Bed Sheets: How We Turn Seaweed into Luxury Fabrics) in view of Qin (Alginate fibers: an overview of the production process and applications in wound management), Rioux (Characterization of polysaccharides extracted from brown seaweeds.) and Meister (EP0860522A1).and further in view of Wang (CN 105457094A). Marialma, Qin, Rioux and Meister are relied upon as set forth above. Marialma, Qin, Rioux and Meister do not teach 0.5-5 wt% of calcium chloride in the spinning solution. Wang teaches that 3% calcium chloride is added to the alginate from seaweed spinning solution to provide crosslinking benefits (page 2, last paragraph, page 3, paragraph (1), claim 3). It would have been obvious to one of ordinary skill in the art at the time the invention was made to modify the methods of Marialma, Qin, Rioux and Meister by using a 3% calcium chloride material based on the amount of cellulose in the spinning solutions as Wang teaches CaCl2 is effectively added at this amount to crosslink the alginate before spinning into fibers. Claim 14 is rejected under 35 U.S.C. 103 as being unpatentable over Marialma (Bed Sheets: How We Turn Seaweed into Luxury Fabrics) in view of Qin (Alginate fibers: an overview of the production process and applications in wound management), Rioux (Characterization of polysaccharides extracted from brown seaweeds.) and Meister (EP0860522A1) and further in view of Powell (Seaweed fabric sleepwear is here and it’s amazing). Marialma, Qin, Rioux and Meister are relied upon as set forth above. Marialma, Qin, Rioux and Meister do not teach preparing garments. Powell teaches it is known to manufacture garments such as loungewear and sleepwear from seaweed fabrics for the benefit of producing calming and moisturizing fabrics which are sustainably sourced (pages 1/13=2/13). It would have been obvious to one of ordinary skill in the art at the time the invention was made to modify the methods of Marialma, Qin, Rioux and Meister by making the fibers produced into garments as Powell teaches making garments such as loungewear and sleepwear from seaweed based fibers provides the benefit of garments with calming and moisturizing benefits and seaweed is an eco-friendly source of fiber material which can be sustainably harvested. Claim 15 is rejected under 35 U.S.C. 103 as being unpatentable over Marialma (Bed Sheets: How We Turn Seaweed into Luxury Fabrics) in view of Qin (Alginate fibers: an overview of the production process and applications in wound management), Rioux (Characterization of polysaccharides extracted from brown seaweeds.) and Meister (EP0860522A1) and further in view of Tucker (Nienke Hoogvliet’s Sea Me furniture is made from seaweed.). Marialma, Qin, Rioux and Meister are relied upon as set forth above. Marialma, Qin, Rioux and Meister do not specify furniture. Tucker teaches it is known to manufacture fabric for furniture that has been hand woven from seaweed yarn with the benefit of having soft fibers (page 2/14-3/14). It would have been obvious to one of ordinary skill in the art at the time the invention was made to modify the methods of Marialma, Qin, Rioux and Meister by making the fibers produced into furniture upholstery fabrics as Tucker teaches making furniture fabrics woven from seaweed based yarns provides the benefit of softer fabrics to the furniture. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to AMINA S KHAN whose telephone number is (571)272-5573. The examiner can normally be reached Monday-Friday, 9am-5:30pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Angela Brown-Pettigrew can be reached at 571-272-2817. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /AMINA S KHAN/ Primary Examiner, Art Unit 1761
Read full office action

Prosecution Timeline

Apr 14, 2022
Application Filed
Jun 13, 2022
Response after Non-Final Action
Jan 30, 2026
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12600924
NON-CATIONIC SOFTENERS AND METHODS OF USE
2y 5m to grant Granted Apr 14, 2026
Patent 12601111
MEDICINAL FABRIC FOR DERMATOLOGICAL USE CASES AND ASSOCIATED METHOD FOR MANUFACTURING THE SAME
2y 5m to grant Granted Apr 14, 2026
Patent 12577726
VESICLE-COATED FIBERS AND METHODS OF MAKING AND USING
2y 5m to grant Granted Mar 17, 2026
Patent 12577728
METHOD OF DYEING FABRIC USING MICROORGANISMS
2y 5m to grant Granted Mar 17, 2026
Patent 12570902
STORAGE STABLE LIQUID FUGITIVE COLORED FIRE-RETARDANT CONCENTRATES
2y 5m to grant Granted Mar 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
48%
Grant Probability
91%
With Interview (+43.2%)
3y 4m
Median Time to Grant
Low
PTA Risk
Based on 1008 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month